Skip to main content
TipRanks
Go Ultimate75% OFF

Arbutus Biopharma (ABUS) Ownership - Who Owns Arbutus Biopharma?

1,289 Followers

Arbutus Biopharma (ABUS) Ownership Overview

  • 19.68% Insiders
  • 12.34% Mutual Funds
  • 28.01% Other Institutional Investors
  • 14.39% ETFs
  • 25.57% Public Companies and Individual Investors

The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 54.75% of the company’s stock is owned by Institutional Investors, 19.68% is owned by Insiders, and 25.57% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026 $69,383,746
Sep 30, 2026Aristeia Capital Llc$999,020

Top Shareholders

ABUS top shareholders
Holder# of SharesType% HoldingValue
Roivant Sciences Ltd.29,880,079Insider19.49%121,014,320
BlackRock, Inc.14,515,428Institution9.47%58,787,483
Ishares8,329,711Institution5.43%33,735,330
Vanguard Index Funds6,829,678Institution4.46%27,660,196
Vanguard6,023,848Institution3.93%24,396,584
Spdr4,112,904Institution2.68%16,657,261
Morgan Stanley Insight Fund2,728,775Institution1.78%11,051,539
Michael Rockefeller2,281,856Institution1.49%9,241,517
Morgan Stanley Institutional Fund Inc1,978,273Institution1.29%8,012,006
Fidelity Salem Street Trust1,933,959Institution1.26%7,832,534

Top Mutual Fund Holders

ABUS top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds6,829,678Institution4.46%27,660,196
Morgan Stanley Insight Fund2,728,775Institution1.78%11,051,539
Morgan Stanley Institutional Fund Inc1,978,273Institution1.29%8,012,006
Fidelity Salem Street Trust1,933,959Institution1.26%7,832,534
Fidelity Concord Street Trust1,585,423Institution1.03%6,420,963
Vanguard Scottsdale Funds1,110,321Institution0.72%4,496,800
Tiaa-cref Funds511,796Institution0.33%2,072,774
Schwab Capital Trust489,116Institution0.32%1,980,920
Vanguard World Fund435,449Institution0.28%1,763,568
Goldman Sachs Trust385,130Institution0.25%1,559,777

Top ETF Holders

ABUS top ETF holders
Holder# of SharesType% HoldingValue
iShares Russell 2000 ETF, IWM ETF4,065,066Institution2.65%16,463,517
Vanguard Total Stock Market ETF, VTI ETF3,136,954Institution2.05%13,206,576
SPDR S&P BIOTECH ETF, XBI ETF2,882,064Institution1.88%11,643,539
iShares Russell 2000 Growth ETF, IWO ETF1,524,214Institution0.99%6,173,067
Vanguard Extended Market ETF, VXF ETF1,377,090Institution0.90%5,797,549
iShares Biotechnology ETF, IBB ETF1,247,111Institution0.81%5,050,800
Janus Henderson Small Cap Growth Alpha ETF, JSML ETF951,290Institution0.62%3,843,212
Vanguard Russell 2000 ETF, VTWO ETF944,696Institution0.62%3,977,170
Schwab U.S. Small-Cap ETF, SCHA ETF641,405Institution0.42%2,591,276
SPDR S&P Kensho New Economies Composite ETF, KOMP ETF549,077Institution0.36%2,218,271

FAQ

Who Owns Arbutus Biopharma (ABUS)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 54.75% of the company's stock is held by institutional investors, 19.68% is held by insiders, and 25.57% is held by public companies and individual investors.
What percentage of Arbutus Biopharma (ABUS) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 54.75% of Arbutus Biopharma (ABUS) stock is held by institutional investors: 12.34% by mutual funds, 14.39% by ETFs and 28.01% by other institutional investors.
What percentage of Arbutus Biopharma (ABUS) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 25.57% of Arbutus Biopharma (ABUS) stock is held by public companies and individual investors.
Who owns the most shares of Arbutus Biopharma (ABUS)?
Roivant Sciences Ltd. owns the most shares of Arbutus Biopharma (ABUS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.